Acceleron Pharma (United States)
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Acceleron Pharma (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
35%
Total
Publications
367
Total Open
Publications
128
Total
Citations
16K
Open Access
Percentage
35%
Total
Publications
367
Total Open
Publications
128
Total
Citations
16K
Breakdown
Publisher Open
8%
Both
19%
Other Platform Open
6%
Closed
67%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 40%
38
Hybrid 26%
25
No Guarantees 34%
33
Other Platform Open
Domain 74%
67
Institution 30%
27
Other Internet 24%
22
Public 2%
2
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 67 |
DOI | Other Internet | 18 |
Unknown Repository | Other Internet | 4 |
Europe PMC | Domain | 4 |
DASH - Digital Access to Scholarship at Harvard | Institution | 4 |
DANS - Data Archiving and Networked Services | Institution | 4 |
University of Modena and Reggio Emilia - IRIS UNIMORE | Institution | 3 |
University of Florence - Florence Research | Institution | 3 |
Universita Degli Studi Di Milano - Archivio Istituzionale della Ricerca | Institution | 3 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 3 |